{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T15:14:47Z","timestamp":1777907687352,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["310347\/2014-9"],"award-info":[{"award-number":["310347\/2014-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ejps.2017.09.037","type":"journal-article","created":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T23:30:22Z","timestamp":1506555022000},"page":"57-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["New mesalamine polymeric conjugate for controlled release: Preparation, characterization and biodistribution study"],"prefix":"10.1016","volume":"111","author":[{"given":"Aina L.A.","family":"Cesar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda A.","family":"Abrantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luana","family":"Farah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel O.","family":"Castilho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valbert","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone O.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana D.","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 A.G.","family":"Faraco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejps.2017.09.037_bb0005","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s12325-015-0206-4","article-title":"Release of 5-aminosalicylic acid (5-ASA) from mesalamine formulations at various pH levels","volume":"32","author":"Abinusawa","year":"2015","journal-title":"Adv. Ther."},{"issue":"16","key":"10.1016\/j.ejps.2017.09.037_bb0010","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.carres.2006.08.015","article-title":"Dextran and 5-aminosalicylic acid (5-ASA) conjugates: synthesis, characterisation and enzymic hydrolysis","volume":"341","author":"Ahmad","year":"2006","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejps.2017.09.037_bb0015","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ejmech.2014.10.081","article-title":"Benzimidazoleeibuprofen\/mesalamine conjugates: potential candidates for multifactorial diseases","volume":"89","author":"Bansal","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"9573","key":"10.1016\/j.ejps.2017.09.037_bb0020","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2017.09.037_bb0025","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/ptr.5401","article-title":"Anti-TNF-\u03b1 activity of Brazilian medicinal plants and compounds from Ouratea semiserrata","volume":"29","author":"Campana","year":"2015","journal-title":"Phytother. Res."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2017.09.037_bb0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijpharm.2008.09.058","article-title":"Poly(ethylene glycol)-mesalazine conjugate for colon specific delivery","volume":"368","author":"Canevari","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ejps.2017.09.037_bb9000","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.neuroscience.2010.02.069","article-title":"Chondroitin sulfate inhibits lipopolysaccharide-induced inflammation in rat astrocytes by preventing nuclear factor kappa B activation","volume":"167","author":"Ca\u00f1as","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejps.2017.09.037_bb0035","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.actbio.2009.02.002","article-title":"Fabrication and characterization of poly (\u03b3-glutamic acid)-graft-chondroitin sulfate\/polycaprolactone porous scaffolds for cartilage tissue engineering","volume":"5","author":"Chang","year":"2009","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejps.2017.09.037_bb0040","series-title":"Organic Chemistry","author":"Clayden","year":"2012"},{"issue":"2","key":"10.1016\/j.ejps.2017.09.037_bb0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.imlet.2014.04.004","article-title":"Inflammatory bowel disease","volume":"161","author":"Corridoni","year":"2014","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.ejps.2017.09.037_bb0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"issue":"28","key":"10.1016\/j.ejps.2017.09.037_bb0060","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.3748\/wjg.v20.i28.9458","article-title":"Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis","volume":"20","author":"da Silva","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.ejps.2017.09.037_bb0070","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd1088","article-title":"The dawning era of polymer therapeutics","volume":"2","author":"Duncan","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.ejps.2017.09.037_bb0075","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jpba.2004.02.004","article-title":"Characterization of the role of physicochemical factors on the hydrolysis of dipyrone","volume":"35","author":"Erg\u00fcn","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.ejps.2017.09.037_bb0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1586\/ecp.12.2","article-title":"Mesalamine in the treatment and maintenance of remission of ulcerative colitis","volume":"5","author":"Ham","year":"2012","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejps.2017.09.037_bb0085","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1759720X10383076","article-title":"Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations","volume":"2","author":"Henrotin","year":"2010","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"issue":"10","key":"10.1016\/j.ejps.2017.09.037_bb0090","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1016\/j.bmcl.2012.03.102","article-title":"Synthesis and characterization of folic acid modified water-soluble chitosan derivatives for folate-receptor-mediated targeting","volume":"22","author":"Jing","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.ejps.2017.09.037_bb0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.addr.2012.10.014","article-title":"Polymer-drug conjugates: origins, progress to date and future directions","volume":"65","author":"Kope\u010dek","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ejps.2017.09.037_bb0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bioeng.2006.05.010","article-title":"Synthesis and characterizations of amphiphilic poly(l-lactide)-grafted chondroitin sulfate copolymer and its application as drug carrier","volume":"24","author":"Lee","year":"2007","journal-title":"Biomol. Eng."},{"issue":"16","key":"10.1016\/j.ejps.2017.09.037_bb0105","doi-asserted-by":"crossref","first-page":"8564","DOI":"10.1021\/cr500131f","article-title":"Biodegradable polymer nanogels for drug\/nucleic acid delivery","volume":"115","author":"Li","year":"2015","journal-title":"Chem. Rev."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2017.09.037_bb0110","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijpharm.2007.05.028","article-title":"Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles","volume":"342","author":"Mladenovska","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2017.09.037_bb0115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijpharm.2007.05.059","article-title":"5-ASA loaded chitosan\u2013Ca\u2013alginate microparticles: preparation and physicochemical characterization","volume":"345","author":"Mladenovska","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.09.037_bb0120","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1021\/bm0600264","article-title":"Bio-based hydrogels prepared by cross-linking of microbial poly(\u00e7-glutamic acid) with various saccharides","volume":"7","author":"Murakami","year":"2006","journal-title":"Biomacromolecules"},{"issue":"9853","key":"10.1016\/j.ejps.2017.09.037_bb0125","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","article-title":"Ulcerative colitis","volume":"380","author":"Ord\u00e1s","year":"2012","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.1016\/j.ejps.2017.09.037_bb0130","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ijpharm.2011.11.013","article-title":"Synthesis and biological evaluation of radiolabeled photosensitizer linked bovine serum albumin nanoparticles as a tumor imaging agent","volume":"422","author":"Ozgur","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"8\u20139","key":"10.1016\/j.ejps.2017.09.037_bb0135","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.progpolymsci.2007.05.008","article-title":"Polymer-drug conjugation, recent achievements and general strategies","volume":"32","author":"Pasut","year":"2007","journal-title":"Prog. Polym. Sci."},{"issue":"7","key":"10.1016\/j.ejps.2017.09.037_bb0140","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00228-015-1862-7","article-title":"Review article: the pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment","volume":"71","author":"Quetglas","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2017.09.037_bb0145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0168-3659(87)90035-6","article-title":"A simple equation for description of solute release II. Fickian and anomalous release from swellable devices","volume":"5","author":"Ritger","year":"1987","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ejps.2017.09.037_bb0150","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/0250-474X.117420","article-title":"Dextran Carrier macromolecules for colon-specific delivery of 5-aminosalicylic acid","volume":"75","author":"Shrivastava","year":"2013","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.09.037_bb0155","series-title":"Identifica\u00e7\u00e3o espectrom\u00e9trica de compostos org\u00e2nicos","author":"Silverstein","year":"2000"},{"issue":"4","key":"10.1016\/j.ejps.2017.09.037_bb0160","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.apradiso.2007.11.002","article-title":"Radiolabeling procedure, quality control and stability of 99mTc-labeled chondroitin sulfate: a new approach of targeting osteoarthritis","volume":"66","author":"Sobal","year":"2007","journal-title":"Appl. Radiat. Isot."},{"issue":"3","key":"10.1016\/j.ejps.2017.09.037_bb0165","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v25.i3.10","article-title":"Mucoadhesion and the gastrointestinal tract","volume":"25","author":"Varum","year":"2008","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"issue":"3","key":"10.1016\/j.ejps.2017.09.037_bb0170","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.pop.2011.06.001","article-title":"Inflammatory bowel disease","volume":"38","author":"Walsh","year":"2011","journal-title":"Prim. Care"},{"issue":"1\u20132","key":"10.1016\/j.ejps.2017.09.037_bb0175","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijpharm.2014.04.040","article-title":"Preparation and evaluation of colon adhesive pellets of 5-aminosalicylic acid","volume":"468","author":"Xu","year":"2014","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717305274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717305274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T20:46:23Z","timestamp":1536698783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098717305274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":34,"alternative-id":["S0928098717305274"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2017.09.037","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New mesalamine polymeric conjugate for controlled release: Preparation, characterization and biodistribution study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2017.09.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}